Adaptive Biotechnologies CEO Julie Rubinstein Sells 38,120 Shares in March 2026

Adaptive Biotechnologies Corporation (ADPT) has announced that President and Chief Operating Officer Julie Rubinstein has made several transactions involving shares of the company's stock. On March 25, 2026, Rubinstein sold 19,060 shares at a price of $14.27 per share and bought 14,722 shares at $7.27 per share. On March 26, 2026, Rubinstein sold 19,060 shares at $14.12 per share and bought 14,722 shares at $7.27 per share. Finally, on March 24, 2026, Rubinstein sold 19,060 shares at $13.7 per share and bought 14,722 shares at $7.27 per share.